ChiCTR2200057850Not yet recruiting
Untitled Trial
Efficacy and safety of xindilimab combined with oxaliplatin / capecitabine (XELOX) in neoadjuvant therapy of locally advanced gastric cancer: a prospective, single center, phase II study
HENAN PROVINCIAL PEOPLE'S HOSPITALPhase 2Chinese Clinical Trial Registry
Study focus
- Disease/Condition
- gastric cancer
Sponsor & location
- Primary sponsor
- HENAN PROVINCIAL PEOPLE'S HOSPITAL
- Funder
- The cost of continuous blood glucose test and ambulatory electrocardiogram in this study shall be paid by themselves according to the hospitalization charging process; However, the cost of subsequent
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Mar 08, 2023
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200057850
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200057850 through Pure Global AI's free database. This Phase 2 trial is sponsored by HENAN PROVINCIAL PEOPLE'S HOSPITAL and is currently Not yet recruiting. The study focuses on gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.